Dimensional Fund Advisors LP Ab Cellera Biologics Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.73 - $4.73 $3,617 - $6,267	1,325 Added 0.74%	179,882 $532,000
Q1 2024 May 10, 2024	BUY	$4.29 - $5.97 $360,317 - $501,420	83,990 Added 88.82%	178,557 $808,000
Q4 2023 Feb 07, 2024	BUY	$3.91 - $5.93 $20,300 - $30,788	5,192 Added 5.81%	94,567 $539,000
Q3 2023 Nov 09, 2023	BUY	$4.6 - $7.95 $6,016 - $10,398	1,308 Added 1.49%	89,375 $411,000
Q2 2023 Aug 09, 2023	BUY	$5.66 - $7.59 $22,521 - $30,200	3,979 Added 4.73%	88,067 $568,000
Q1 2023 May 12, 2023	SELL	$7.31 - $11.18 $18,859 - $28,844	-2,580 Reduced 2.98%	84,088 $634,000
Q4 2022 Feb 09, 2023	BUY	$9.48 - $14.52 $43,456 - $66,559	4,584 Added 5.58%	86,668 $877,000
Q3 2022 Nov 10, 2022	BUY	$9.2 - $13.68 $755,172 - $1.12 Million	82,084 New	82,084 $812,000

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.